Foundational Treatments for Tomorrow
SOMA Nutraceuticals, Inc., a Texas wholly owned subsidiary of AngioSoma, Inc., provides nutraceutical products, both patented and proprietary formulated, that integrate fully into AngioSoma, Inc.’s mission statement of having a complete solution for the treatment of cardiovascular disease – prior to the need for treatment to prevent the need for treatment (SOMA Nutraceuticals, Inc.), at treatment to bring patients up to a foundational level (Liprostin™ and the OmniCath I & II), and once patients have gotten to a foundational level to keep them at that level (the Transdermal PGE-1 Patch)
Our Nutraceutical Products
These products have previously generated over ten million dollars ($10,000,000) in sales, through various sales outlets including GNC, while these products were owned and marketed by Endovasc, Inc. in 2005 and 2006:
- A patented (U.S. Patent 7,074,812, “Development of Muscle Mass in a Mammal“) nutraceutical using either natural or synthetic nicotine in a patented method for substantially accelerating the development of muscle mass and strength.
- A proprietary formulated product for a sleep aide.
- A proprietary formulated product for staying awake and alert.
- A proprietary formulated product for strength and stamina.
- A proprietary formulated product for enhancing libido while aiding erections.